04/25/2024
7:30 AM | Candel Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/25/2024
6:33 AM | Candel Therapeutics (Filer)
| Form 10-K/A | |
04/11/2024
8:00 AM | Candel Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/09/2024
7:30 AM | Candel Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/04/2024
7:30 AM | Candel Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/28/2024
7:00 AM | Candel Therapeutics (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
03/28/2024
7:16 AM | Candel Therapeutics (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
|
03/28/2024
6:45 AM | Candel Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/06/2024
7:00 AM | Candel Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/13/2024
8:00 AM | Candel Therapeutics (Filer)
| Form 424B5 | |
02/13/2024
6:45 AM | Candel Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/19/2024
7:30 AM | Candel Therapeutics (Issuer)
Schoch Charles (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
01/12/2024
3:30 PM | Candel Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/03/2024
7:30 AM | Candel Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/12/2023
7:30 AM | Candel Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/30/2023
4:00 PM | Amello Jason (Reporting)
Candel Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/30/2023
4:00 PM | Barone Francesca (Reporting)
Candel Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/30/2023
4:00 PM | Candel Therapeutics (Issuer)
Nichols William Garrett (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/30/2023
4:00 PM | Candel Therapeutics (Issuer)
Tak Paul Peter (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/30/2023
4:00 PM | Candel Therapeutics (Issuer)
Tyagarajan Seshu (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/28/2023
8:00 AM | Candel Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/09/2023
7:16 AM | Candel Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/09/2023
7:31 AM | Candel Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/06/2023
7:53 AM | Candel Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/06/2023
7:15 AM | Candel Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/18/2023
10:31 AM | Candel Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/26/2023
7:30 AM | Candel Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/10/2023
7:31 AM | Candel Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/10/2023
7:15 AM | Candel Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/29/2023
8:00 AM | Candel Therapeutics (Issuer)
Nabel Gary J. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/29/2023
8:00 AM | Aguilar-Cordova Estuardo (Reporting)
Candel Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/29/2023
8:00 AM | Candel Therapeutics (Issuer)
PAPA JOSEPH C (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/29/2023
8:00 AM | Benz Edward J. JR (Reporting)
Candel Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/29/2023
8:00 AM | Candel Therapeutics (Issuer)
Martell Christopher (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/29/2023
8:00 AM | Candel Therapeutics (Issuer)
Manning Paul B (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/29/2023
8:00 AM | Candel Therapeutics (Issuer)
Nguyen Diem (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/29/2023
8:00 AM | Candel Therapeutics (Issuer)
Gaeta Renee (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/29/2023
7:31 AM | Candel Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/13/2023
7:31 AM | Candel Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/09/2023
7:45 AM | Candel Therapeutics (Issuer)
Loggia Nicoletta (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/09/2023
7:30 AM | Candel Therapeutics (Issuer)
Loggia Nicoletta (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
348 million Americans lives to END as we know it? (Ad) 348 million American lives are about to change FOREVER....
Because thanks to one shocking A.I. development I'm revealing for the first time today... To see my free research, simply click here now. |
06/08/2023
7:15 AM | Candel Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/23/2023
7:00 AM | Candel Therapeutics (Filer)
| Form DEF 14A | |
05/23/2023
7:01 AM | Candel Therapeutics (Filer)
| Form ARS | |
05/19/2023
8:15 AM | Candel Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/11/2023
7:46 AM | Candel Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/11/2023
7:31 AM | Candel Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
